Clinical Trials Directory

Trials / Unknown

UnknownNCT04627350

Early Detection of Lung Cancer in Czech High-risk Asymptomatic Individuals

Status
Unknown
Phase
Study type
Observational
Enrollment
3,200 (estimated)
Sponsor
Charles University, Czech Republic · Academic / Other
Sex
All
Age
55 Years – 74 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to evaluate and optimize entry criteria for the proposed programme for early detection of lung cancer in the Czech Republic. An estimated 3200 high-risk (age 55-74 years, \>30 pack-years) asymptomatic individuals will undergo baseline low-dose chest CT (LDCT) and a follow-up LDCT at 1 year. Patients with poor performance status (PS) 2-4, history of malignancy in the past 10 years, chest CT in the past 1 year, bodyweight \>140kg will not be included. The patients will fill out a questionnaire with basic data, including smoking history (pack-years), history of previous malignancy, CT imaging of the thorax, and will undergo spirometry. Outcomes of the study include: * optimization of entry criteria, optimization of timing of a follow-up LDCT and management of the patients, proposal of quality assurance indicators * influence of screening on the stage of lung cancer at the time of the diagnosis and life-years lost * cost-effectiveness of the screening program * evaluation of the diagnostic yield for secondary findings (pulmonary fibrosis, cardiovascular risk)

Conditions

Interventions

TypeNameDescription
OTHERResponse to pulmonary finding (nodule, mass)Follow-up low-dose CT, PET-CT, tissue sampling (transparietal biopsy, bronchoscopy, resection), contrast-enhanced CT of the thorax

Timeline

Start date
2020-08-01
Primary completion
2023-12-31
Completion
2023-12-31
First posted
2020-11-13
Last updated
2020-11-13

Locations

1 site across 1 country: Czechia

Source: ClinicalTrials.gov record NCT04627350. Inclusion in this directory is not an endorsement.